Literature DB >> 19615936

Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium.

Mahmoud Reza Pourkarim1, Jannick Verbeeck, Mustafizur Rahman, Samad Amini-Bavil-Olyaee, An-Marie Forier, Philippe Lemey, Piet Maes, Marc Van Ranst.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) is primarily transmitted from mother to child, by sexual contact, intravenous drug abuse, or unsafe health care-related injection practices. Despite increased safety efforts, nosocomial acquired hepatitis B infection remains problematic.
OBJECTIVES: A large HBV outbreak was investigated comprising 36 patients with acute HBV infection in a primary care physician's practice. STUDY
DESIGN: In a retrospective study (2003-2008), 36 serum samples from patients with acute HBV infection were collected. They had received several injections by the same physician at least 3 months before the onset of clinical symptoms. As a control group, sera were collected from HBV patients from other physicians from the same province. Full-length HBV genomes were amplified and were phylogenetically analysed.
RESULTS: HBV complete genomes of 32 patients were successfully amplified and sequenced, and clustered together with the reference genotype A, subgenotype A2 strains. We also analysed 26 control HBV genotype A samples. All 32 HBV strains from the patient group clustered in a monophyletic branch with a bootstrap value of 100, whereas the control samples branched separately in another clade. The genetic distance value showed small differences within the patients group, whereas the rate within the control group was seven times higher. These observations confirm that the source of transmission was clearly different in both groups.
CONCLUSION: Maximum likelihood analysis and genetic distance calculations based on the full-length genomes of HBV strains isolated from patients and controls provided strong evidence for a common nosocomial source of infection for all 32 patient cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615936     DOI: 10.1016/j.jcv.2009.06.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  Recent population expansions of hepatitis B virus in the United States.

Authors:  Sumathi Ramachandran; Michael A Purdy; Guo-liang Xia; David S Campo; Zoya E Dimitrova; Eyasu H Teshale; Chong Gee Teo; Yury E Khudyakov
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

Review 2.  Reconstruction of the origin and dispersal of the worldwide dominant Hepatitis B Virus subgenotype D1.

Authors:  Nídia Sequeira Trovão; Marijn Thijssen; Bram Vrancken; Andrea-Clemencia Pineda-Peña; Thomas Mina; Samad Amini-Bavil-Olyaee; Philippe Lemey; Guy Baele; Mahmoud Reza Pourkarim
Journal:  Virus Evol       Date:  2022-04-08

Review 3.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 4.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Guidelines for the detection of a common source of hepatitis B virus infections.

Authors:  Mahmoud Reza Pourkarim; Marc Van Ranst
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

6.  Knowledge, attitudes and practice of Iranian medical specialists regarding hepatitis B and C.

Authors:  Ali Kabir; Seyed Vahid Tabatabaei; Siamak Khaleghi; Shahram Agah; Amir Hossein Faghihi Kashani; Mehrdad Moghimi; Fahimeh Habibi Kerahroodi; Seyed-E-Hoda Alavian; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

7.  Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.

Authors:  Savanna Reid
Journal:  Indian J Community Med       Date:  2012-04

8.  Mutations and CpG islands among hepatitis B virus genotypes in Europe.

Authors:  Chengyao Zhong; Zhiwei Hou; Jihua Huang; Qingdong Xie; Ying Zhong
Journal:  BMC Bioinformatics       Date:  2015-02-05       Impact factor: 3.169

9.  Significant proportion of acute hepatitis B in Poland in 2010-2014 attributed to hospital transmission: combining surveillance and public registries data.

Authors:  Małgorzata Stępień; Karolina Zakrzewska; Magdalena Rosińska
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

10.  Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach.

Authors:  Evangelia-Georgia Kostaki; Timokratis Karamitros; Garyfallia Stefanou; Ioannis Mamais; Konstantinos Angelis; Angelos Hatzakis; Anna Kramvis; Dimitrios Paraskevis
Journal:  Elife       Date:  2018-08-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.